{ "tag": [ "compiled" ], "id": "ocds-h6vhtk-04c7ad-2024-12-27T12:20:47Z", "date": "2024-12-27T12:20:47Z", "ocid": "ocds-h6vhtk-04c7ad", "description": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by 24/12/2024. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR

The business case including the recommendation to award the contract under Provider Selection Regime Process C was approved at the ICB Strategic Finance & Commissioning Committee on the 12/09/2024.

The options paper for this service was presented at the following panels and committees:
* SWH HCP Finance and Commissioning Committee - 22/08/2024
* ICB Commissioning and Contracting Panel - 29/08/2024 (extraordinary meeting)
* Financial Scrutiny Panel - 06/09/2024
* HWE ICB Strategic Finance and Commissioning Committee - 12/09/2024

The were no conflict or potential conflicts declared.

The decision to award this contract in line with Direct Award Process C was based on evaluation against the five required key criteria as follows:
* Quality and Innovation - Assured - HWE ICB are assured that the provider is delivering a safe and effective service as required by the specification and contract they are currently delivering. This criterion was reviewed in line with the Quality Impact Assessment.
* Value - Assured - HWE ICB are assured that the provider is delivering value for money and providing an innovative, sustainable, high-quality service with positive outcomes for patients within the financial envelop.
* Integration, Collaboration and Service Sustainability - Assured - HWE ICB are assured that the provider is positively impacting on the Integrated Care System through their integration and collaboration delivered as a requirement of the specification or alternative elements linked to the delivery.
* Improving Access, Reducing Health Inequalities and Facilitating Choice - Assured - HWE ICB are assured that the provider is meeting needs of the population to ensure equitable access and choice as required by the specification and contract. This criterion was reviewed in line with the Equality Impact Assessment.
* Social Value - Assured - HWE ICB are assured that the provider is delivering in line with the HWE Green Plan, supporting with the implementation of carbon reduction and increase in initiatives which positively impact on the wider determinants of health.

There is currently no alternative local provider for the service and the main benefits include:
* Reducing avoidable A&E attendances and GP appointments and costs associated with these attendances, and potential patient transport costs to attend out of area appointments mainly Royal Free and University College London.
* A locally agreement price for the activity.
* Patient experience and outcomes including self-manage their condition, care closure to home, and seamless care between community, secondary care and primary care.", "initiationType": "tender", "tender": { "id": "ocds-h6vhtk-04c7ad", "legalBasis": { "id": "32014L0024", "scheme": "CELEX" }, "title": "SWH - Verulam Chronic Migraine Service 25/27", "status": "complete", "classification": { "scheme": "CPV", "id": "85100000", "description": "Health services" }, "mainProcurementCategory": "services", "description": "The chronic migraine service is provided by Neecare Health Care Ltd
The service undertakes clinical management of chronic migraine for patients who suffer persistent headache.

Neecare chronic migraine service provides clinical intervention for the management of chronic migraine by administering Botulinum injection including regular therapy.

Patients are referred by Neurologist having been diagnosed with Chronic Migraine and meet NICE Guidelines for Botulinum Injection administration.

To confirm, as per the PSR direct award process C, the existing provider is satisfying the existing contract, delivering a good service, meeting all KPIs, with no quality concerns with very good feedback from Clinicians and patients and are likely to satisfy the new contract, The proposed contracting arrangements are not changing from the existing contract.", "lots": [ { "id": "1", "description": "The Chronic Migraine Clinic provide treatment for patients who suffer from persistence headache of:
* Either tension-type and/or migraine quality and occurs on >=15 days per month for at least 3 months.
* No medication overuse.

A strict referral criterion ensures patients would have to see a Neurologist to be diagnosed with Chronic Migraine and then meets the NICE Guidelines for Botulinum administration.
As such the clinic only accepts referrals from a Neurologist who has diagnosed Chronic Migraine in the patient and who fulfil the NICE criteria.

The clinic maintains close links with the Neurology department at East & North Hertfordshire Trust to receive appropriate support, resources, and education.

The clinic offers face to face and virtual educational sessions about chronic migraine with clearly defined pathway.

The contract is for one year with option to renew for a further one year based on FOT of PS77, 748. Additional information: The contract is for one year with option to renew for a further one year based on FOT of PS77, 748. From April 2025 to March 2027", "awardCriteria": { "criteria": [ { "name": "The existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard", "type": "quality", "description": "100" }, { "name": "Price", "type": "cost", "description": "0" } ] }, "hasOptions": true, "options": { "description": "1 year with option to extend for a further 1 year" }, "status": "cancelled" } ], "items": [ { "id": "1", "deliveryAddresses": [ { "region": "UKH23" } ], "relatedLot": "1" } ], "procurementMethod": "limited", "procurementMethodDetails": "Award procedure without prior publication of a call for competition", "coveredBy": [ "GPA" ], "procurementMethodRationaleClassifications": [ { "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL", "id": "D_REPETITION_EXISTING", "description": "New works/services, constituting a repetition of existing works/services and ordered in accordance with the strict conditions stated in the directive" } ], "procurementMethodRationale": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by 24/12/2024. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR", "amendments": [ { "id": "1", "description": "This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. This contract has now been formally awarded using direct award process C. This contract has now been formally awarded using Direct Award Process CThe contract award date is 27/12/2024 and the standstill period took place between 12th December 2024 to 24th December 2024. The business case including recommendation to award the contract under Provider Selection Process C was approved by the ICB's Strategic Finance and Commissioning Committee on the 22nd of November 2024 and there were no recorded or potential conflicts of Interest of individuals making the decision declared at this meeting. The services is intended to be provided between 1st April 2025 and 31st March 2026 with the contract structured as one year plus an optional one year extension. The maximum value of the new contract is PS77.748 per annum should the optional extension be used, the maximum contract value for the 2 years period is PS155,496." } ] }, "awards": [ { "id": "040156-2024-1", "relatedLots": [ "1" ], "status": "active", "suppliers": [ { "id": "GB-FTS-132667", "name": "Verulam Chronic Migraine Injection Clinic" } ] } ], "parties": [ { "id": "GB-FTS-89502", "name": "NHS Hertfordshire and West Essex Integrated Care Board", "identifier": { "legalName": "NHS Hertfordshire and West Essex Integrated Care Board" }, "address": { "streetAddress": "Charter House Parkway", "locality": "Welwyn Garden City", "region": "UKH23", "postalCode": "AL8 6JL", "countryName": "United Kingdom" }, "contactPoint": { "email": "hweicbhv.procurementteam@nhs.net" }, "roles": [ "buyer" ], "details": { "url": "https://www.hertsandwestessex.icb.nhs.uk/", "buyerProfile": "https://www.hertsandwestessex.icb.nhs.uk/", "classifications": [ { "scheme": "TED_CA_TYPE", "id": "REGIONAL_AUTHORITY", "description": "Regional or local authority" }, { "scheme": "COFOG", "id": "07", "description": "Health" } ] } }, { "id": "GB-FTS-132667", "name": "Verulam Chronic Migraine Injection Clinic", "identifier": { "legalName": "Verulam Chronic Migraine Injection Clinic" }, "address": { "streetAddress": "Neecare Ltd 129 London Road ST Albans United Kingdom", "locality": "St Albans", "region": "UKH23", "postalCode": "AL1 1TA", "countryName": "United Kingdom" }, "roles": [ "supplier" ], "details": { "scale": "sme" } } ], "buyer": { "id": "GB-FTS-89502", "name": "NHS Hertfordshire and West Essex Integrated Care Board" }, "contracts": [ { "id": "040156-2024-1", "awardID": "040156-2024-1", "status": "active", "value": { "amount": 155496, "currency": "GBP" }, "dateSigned": "2024-12-12T00:00:00Z" } ], "bids": { "statistics": [ { "id": "1", "measure": "bids", "relatedLot": "1", "value": 1 } ] }, "language": "en" }